Xiaoqun Sun Selected Research

3- fluoro- 3- (3- fluoro- 4- (pyrrolidin- 1- ylmethyl)phenyl)- N- (2- methylpropyl)cyclobutanecarboxamide

1/2014

Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoqun Sun Research Topics

Disease

2	Neoplasms (Cancer) 01/2020 - 01/2019
1	Diarrhea 01/2020
1	Colitis 01/2020
1	Hypersensitivity (Allergy) 01/2019
1	Stomatitis 01/2019
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2019
1	Neutropenia 01/2019
1	Allergic Rhinitis 01/2014

Drug/Important Bio-Agent (IBA)

1	durvalumabIBA 01/2020
1	tremelimumabIBA 01/2020
1	PlatinumIBA 01/2020
1	temsirolimus FDA Link 01/2019
1	MTOR InhibitorsIBA 01/2019
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2019
1	Vinca AlkaloidsIBA 01/2019
1	TOR Serine-Threonine KinasesIBA 01/2019
1	Histamine Antagonists (Antihistamines)IBA 01/2014
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2014
1	3- fluoro- 3- (3- fluoro- 4- (pyrrolidin- 1- ylmethyl)phenyl)- N- (2- methylpropyl)cyclobutanecarboxamideIBA 01/2014
1	ragweed pollenIBA 01/2014
1	fexofenadine (Allegra)FDA LinkGeneric 01/2014

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2020
1	Immunotherapy 01/2020
1	Therapeutics 01/2019